Charge reduction assisted production of diminutive fluid bed granules for high drug load minitablets
[Display omitted] Micronized drug powders are generally unsuitable as tableting feed to produce minitablets due to their cohesivity and poor flow. The silicification of fine paracetamol powder (PCMF) with an optimal concentration range of fumed silica (fSi) [0.7–0.9%, w/w] reduced the net negative c...
Gespeichert in:
Veröffentlicht in: | International journal of pharmaceutics 2022-07, Vol.623, p.121965-121965, Article 121965 |
---|---|
Hauptverfasser: | , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [Display omitted]
Micronized drug powders are generally unsuitable as tableting feed to produce minitablets due to their cohesivity and poor flow. The silicification of fine paracetamol powder (PCMF) with an optimal concentration range of fumed silica (fSi) [0.7–0.9%, w/w] reduced the net negative charge of PCMF and improved powder flow. The optimal fSi concentration range suitable was established through the measurement of charge and flowability of the silicified powders. Silicification of PCMF by physical mix did not satisfactorily overcome the cohesive forces between the PCMF crystals and improve powder flow sufficiently such that it will feed consistently into the smaller die orifices during tableting. Using a specialized fluid bed system with swirling air and side spray, controlled granulation of silicified PCMF packed and agglomerated the interlocking–prone needle shaped PCMF crystals into diminutive granules that are more spherical and free flowing. With optimized fSi concentration (≈ 0.8%, w/w) and granulation process parameters, high drug load diminutive granules (D50≃ 90 μm) were successfully prepared from PCMF as starter seeds (D50≃ 30 μm). Minitablets prepared from the diminutive granules had low weight variation, and were mechanically strong with disintegration time of |
---|---|
ISSN: | 0378-5173 1873-3476 |
DOI: | 10.1016/j.ijpharm.2022.121965 |